Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Walts Alan Edmund, Director. Director active across 1 company, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 1 December 2021. The latest transaction was filed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Alan Edmund Walts serves as a Director of Eloxx Pharmaceuticals, Inc. As a board member, he contributes to overseeing the company's operations and making strategic decisions. Alan brings expertise in the pharmaceutical sector, which is crucial for the growth and innovation of Eloxx. His commitment to corporate governance is essential for ensuring transparency and accountability.